References
Neu HC. Bacterial resistance to fluoroquinolones. Rev Infect Dis 1988; 10: S57–63
Hooper DC, Wolfson JS. Bacterial resistance to the quinolone antimicrobial agents. Am J Med 1989; 87: 17–23S
Segreti J, Gootz TD, Goodman LJ, et al. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis 1992; 165: 667–70
Truckis M, Hooper DC, Wolfson JS. Emerging resistance to fluoroquinolones in staphylococci: an alert [editorial]. Ann Intern Med 1991; 114: 424–5
Muder RR, Brennen C, Goetz AM, et al. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among Gram-negative isolates in a Veterans Affairs medical center. Antimicrob Agents Chemother 1991; 35: 256–8
Richard P, Delangle M-H, Merrien D, et al. Fluoroquinolone use and fluoroquinolone resistance: is there an association?. Clin Infect Dis 1994; 19: 54–9
McGowan Jr JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5: 1033–48
Moody MM, de Jongh CA, Schimpff SC, et al. Long-term amikacin use: effects on aminoglycoside susceptibility patterns of Gram-negative bacilli. JAMA 1982; 248: 1199–202
Betts RF, Valenti WM, Chapman SW, et al. Five-year surveillance of aminoglycoside usage in a university hospital. Ann Intern Med 1984; 100: 219–22
Pozdol T, Postelnick M, Peterson L, et al. Effect of changes in quinolone usage on Pseudomonas aeruginosa (PSAE) susceptibility patterns [abstract no. 234]. 33rd ICAAC, New Orleans, LA: American Society for Microbiology, 1993: 162
National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 4th ed. Approved standard M2-A4. Villanova, PA: NCCLS, 1990
Kresken M, Wiedemann B. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother 1988; 32: 1285–8
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Segreti, J., Connelly, R. Effect of Quinolone Use on Antimicrobial Susceptibility Patterns over a 5-Year Period. Drugs 49 (Suppl 2), 185–187 (1995). https://doi.org/10.2165/00003495-199500492-00035
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199500492-00035